Grants>Animal Models

Autism Speaks Request for Applications: Treatment Research Grants: Full- and Pilot-Level 2012 Cycle

Letter of Intent due: February 23, 2012, 8:00 PM Eastern

Autism Speaks invites both Full- and Pilot-Level Treatment research grant applications to conduct innovative clinical studies of novel interventions for individuals with Autism Spectrum Disorders (ASD) throughout the lifespan. These may include medical approaches including complementary and alternative forms of health care and pharmacological treatments, as well as behavioral and/or psychosocial interventions, and evaluation of the efficacy, safety or therapeutic benefits of all types of interventions. Also appropriate are animal model studies that test the effects of novel compounds for reducing autism symptoms.

For all RFAs, Autism Speaks is focusing on a set of targeted research priorities for 2012. All treatment study projects will be required to demonstrate direct relevance to at least one of these targeted research priorities:

1. Understand environmental risk factors and their interaction with genetic susceptibility to enable prevention and improve diagnosis and treatment

2. Discover biomarkers that can improve risk assessment and subtype stratification that will allow for an individualized approach to treatment

3. Improve quality of life through more effective medicines, behavioral interventions, and technologies

4. Enhance diagnosis and treatment of underserved and under-studied populations, specifically,

• Nonverbal persons with ASD
• Ethnically-diverse and/or low resource communities
• Adults
• Those with medical co-morbidities

5. Disseminate and implement evidence-based clinical practices to the broader community worldwide

IMPORTANT: The relevance of the proposed research to ASD and Autism Speaks’ research priority areas must be explicitly described in the Letter of Intent (LOI) and full application.

Awards
Autism Speaks will make a limited number of treatment research grants determined by the available financial resources.

Full-level research grant
1-3 years
$150,000/year maximum

Pilot-level research grant
1-2 years
$60,000/year maximum

Autism Speaks utilizes a web-based application system for their grant submissions. All applications must be submitted through this system. It is imperative to indicate whether the submission is for the Full- or Pilot-Level Treatment research option.

Research Inquiries
research@autismspeaks.org

Travel Grants for the International Society for Clinical Electrophysiology of Vision Symposium

50th ISCEV Symposium in Valencia (Spain) June 5th to 8th, 2012

14th February 2012. Travel GRANT Application Deadline.

28th February 2012. ABSTRACT Submission DEADLINE.

Two themes have been adopted for this 50th ISCEV meeting.

· Experimental and animal models in visual electrophysiology.

· Electrophysiology and correlation with diseases.

The purpose of the ISCEV Grant program is to assist young colleagues who would otherwise be unable to attend ISCEV meetings. There are currently a minimum of six travel grants, at least three to applicants from the ISCEV region of the symposium and at least three overseas grants. Additional grants may be awarded based on the quality of applications when sufficient budget is available. Travel grants have a value of €500 or €1000 (Euro) for regional and overseas travel respectively. The grants programme does not expect to provide full support but hopefully will provide sufficient assistance that grant-recipients will be able to find local funds for the remainder of the symposium costs. Recipients also receive a free membership to ISCEV for the current year and a reduced registration fee offered by the local organizers. Applicants who are not awarded grants retain the privilege of registering without a late fee, if the early registration deadline has passed.

Applications are made directly to the Secretary-General and will be considered by the ISCEV Awards Committee, which comprises the Secretary General and the three regional ISCEV Vice-Presidents. Applications must contain:

• An abstract for presentation at the symposium. This should be submitted online to the symposium organisers AND sent separately by email to the Secretary-General.

• A statement of circumstances from the applicant describing his/her experience in clinical electrophysiology of vision and the reason for requesting financial assistance. If the applicant is a student or junior member, an additional letter of support from the supervisor is required.

There are no absolute criteria for travel grants; the awards committee will consider scientific merit, the relevance of the submitted abstract to the symposium topics and the benefits to the applicant of participation in the symposium. Repeat applications from previously-successful applicants, multiple applications from the same laboratory, and applications from investigators with more than 5 years of experience in clinical electrophysiology are discouraged.

Deadline for submitting an application is February 28th 2012, and the awardees will be notified by March 21th, 2012.

Call for Applications: Scleroderma Foundation New Investigator Grant

Grant Application Deadline: Sept. 15th annually by 5 p.m. EST

If the 15th falls on a Sat. or Sun., then the following Monday at 5 p.m. EST will be the deadline.

Purpose: The Scleroderma Foundation is seeking applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis (SSc, scleroderma). This grant will support promising research that is likely to lead to individual research project grants.

Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.

Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below).

Mechanism of Support: Applicants may request up to $50,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award.) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.

Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.

Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to SSc.

Appropriate research areas may include but are not limited to the following as they relate to scleroderma:

Vascular manifestations.
Studies of animal models.
Therapeutic modalities.
Mechanisms of end organ damage.
Immunologic studies.
Endothelial cell biology.
Fibroblast biology.
Models and markers of gender and genetic factors.
Cell signaling.
Epidemiology studies.
Matrix biology.
Stem cell biology.
Health services research (e.g. quality of life, health care delivery.)
Study of clinical manifestation.

Scleroderma Foundation
300 Rosewood Drive, Suite 105
Danvers, MA 01923

Phone: (978) 463-5843 (8:30 a.m. to 5 p.m. ET, Monday through Friday)
Fax: (978) 463-5809
Toll-free: (800) 722-HOPE (4673)

American Orthopaedic Society for Sports Medicine Research Awards

AOSSM offers awards for reports of original research in the following categories:

The Cabaud Memorial Award

This award is given to the best paper submitted concerning hard or soft tissue biology, in-vitro research, laboratory or "bench-type" research, or in-vivo animal research.

The O'Donoghue Award

This award is given to the best overall paper which deals with clinical based research or human in-vivo research.

The Excellence in Research Award

This award is given to the best paper submitted in any category to the Awards Committee with a primary author under the age of 40 at the time of the Annual Meeting.

Each award consists of:

$2000 honorarium
Award certificate
Presentation of the paper at the AOSSM Annual Meeting
Consideration of publication in The American Journal of Sports Medicine

Manuscripts to be considered for a research award should be emailed to Bart Mann by November 1st at 5:00 pm Central. Manuscripts may be considered in more than one category so please indicate which award(s) you would like to be considered for.

2012 Senior Scholar in Aging Award

The Ellison Medical Foundation was established and is supported by Lawrence J. Ellison to support biomedical research (including basic biology, basic biomedicine and epidemiology) on aging. The Ellison Medical Foundation Senior Scholar program is designed to support established investigators, working at institutions in the U.S., to conduct research in the basic biological and basic biomedical sciences relevant to understanding lifespan development processes and age-related diseases and disabilities. The award is intended to provide significant support to established investigators in order to allow the development of new, creative research programs by investigators who may not currently be conducting aging research or who may wish to develop new research programs in aging. The Foundation particularly wishes to stimulate new research, which has rigorous scientific foundations, but which may not be currently funded adequately, because of its perceived novelty, its high risk, or because it is from an area where traditional research interests absorb most funding.

Areas of interest include, but are not limited to

Structural biology
Molecular genetics
Studies with model systems ranging from lower eukaryotes to humans
Inquiries testing the relevance of simpler models to human aging
Genetic epidemiology of aging; candidate longevity genes
Aging in the immune system
Host defense molecules in aging systems
Mechanisms of free radical induced cell aging
Mechanisms of aging in various differentiated cell populations
Gene/environment and gene/gene interactions
Integrative physiology
New approaches to age-modulated disease mechanisms

Eligibility

Any interested researcher may submit a Letter of Intent for the 2012 Senior Scholar in Aging award competition; however, current or past Senior Scholar Awardees are not eligible. Applicants for the Senior Scholar Award are expected to furnish evidence of substantial prior scientific creativity and productivity not necessarily targeted to aging heretofore. Evaluation by the Aging Review Group and the Scientific Advisory Board will be based upon the applicant's submission re: scientific contributions to date, the quality of publications, and the importance to aging of the proposed new research. The Aging Review Group and the Scientific Advisory Board will pay close attention to arguments as to why the work does not or would not qualify for support from established sources such as the NIA. Except for compelling circumstances, the awards are not intended to supplement ongoing, already funded programs but, instead, to inspire new directions, which may entail substantial risk. There is no limit on the number of Senior Scholar letters of intent from any one institution. Up to 25 Senior Scholar awards will be made in 2012.

Letter of Intent for Submitting an Application

Instructions and a link to submit a Letter of Intent online for the 2012 application cycle appear on the Applications and Receipt Dates page.

Letters of Intent are due by March 8, 2012 (online submissions must be completed by 11:59 p.m. Eastern Standard Time).

Terms of the Award

The Ellison Medical Foundation Senior Scholar Awards in Aging will be made in early October 2012. Each award will be made for up to $150,000 per year direct cost, plus indirect costs, for up to four years. Funding for years two, three and four is contingent upon submission of an acceptable progress report.

Acceptable uses for award funds include project-related: salaries, other personnel costs, equipment, supplies, resource acquisition and travel. Carry-overs in excess of $25,000 must be approved by the Ellison Medical Foundation Scholars Program Office. Full indirect costs at the NIH Facilities and Administration (F & A) negotiated rate will be provided. The Ellison Medical Foundation does not permit indirect costs on equipment, even for purchases less than $5,000, for initial awardee years of 2005 and later.

For all (new and non-competing renewal) awards supporting research involving human subjects, animal subjects, research collaborations with foreign institutions, biosafety issues, or embryonic stem cells the Foundation will require the following documentation before an award can be made:

Human subjects:

Copies of the protocol submitted to the Institutional Review Board(s)for this project* and the notification of protocol approval from all relevant IRBs (for funded awards an annual update will be required at the time of the progress report).
Documentation from the applicant institution that the principal investigator has completed training on the protection of human research participants.

Animal subjects:

A copy of Institutional Animal Care and Use Committee approval for this project* (an annual update will be required at the time of each progress report).

Foreign component:

A letter of support from the collaborating in-country institution.

Biosafety:Research supported by the Ellison Medical Foundation is expected to conform to the relevant NIH Guidelines for biosafety, including those for handling of hazardous reagents and those for research involving recombinant DNA and gene transfer http://oba.od.nih.gov/rdna/nih_guidelines_oba.html .
A copy of Institutional Biosafety Committee approval for this project* .

Embryonic Stem Cell Research Committee approval of the protocol for this project* if it involves human embryonic stem cells.

* Approval for this project means the EMF funded project, not a similar protocol funded by some other entity.

For further information, contact:

Richard L. Sprott, Ph.D.
Executive Director
The Ellison Medical Foundation
4710 Bethesda Avenue
Suite 204
Bethesda, MD 20814-5226
(301) 657-1830 (Phone)
(301) 657-1828 (Fax)
rsprott@ellisonfoundation.org

Call for Applications: National Spasmodic Dysphonia Association Research Grant Program

The National Spasmodic Dysphonia Association is seeking research applications for new investigator startup grants or post doctoral study focused on research aimed at increasing understanding of spasmodic dysphonia.

Small seed money grants to new or established investigators for up to $20,000 (excluding indirect costs) per year will be awarded. These can be for startup grants enabling successful applicants to subsequently seek funding from the National Institutes of Health or may provide partial support for post doctoral research training relating to spasmodic dysphonia.

We are interested in hypothesis-driven research related to new approaches aimed at increasing understanding of Spasmodic Dysphonia that focuses on the following areas:

Endogenous and environmental risk factors for the development of Spasmodic Dysphonia
Pathophysiology of central nervous system dysfunction in Spasmodic Dysphonia
Animal models for Spasmodic Dysphonia
Novel approaches to the treatment of Spasmodic Dysphonia
Diagnostic tools for Spasmodic Dysphonia
Controlled studies of treatment outcomes in Spasmodic Dysphonia

The deadline to submit an application is March 1 each year.

National Spasmodic Dysphonia Association
300 Park Boulevard
Suite 415
Itasca, IL 60143
Phone: 800-795-6732
Fax: 630-250-4505
NSDA@dysphonia.org